Citation: Bm. Prizant et E. Rubin, Contemporary issues in interventions for autism spectrum disorders: A commentary, J ASSN PERS, 24(3), 1999, pp. 199-208
Authors:
DiPaolo, RS
Rafi, MM
Vyas, V
Toppmeyer, D
Rubin, E
Patel, J
Goodin, S
Medina, M
Medina, P
Zamek, R
Zhang, C
White, E
Gupta, E
Hait, WN
Citation: Rs. Dipaolo et al., Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advancedmalignancies, J CL ONCOL, 17(7), 1999, pp. 2213-2218
Citation: S. Bokkala et al., Effect of chronic ethanol exposure on inositol trisphosphate receptors in WB rat liver epithelial cells, ALC CLIN EX, 23(12), 1999, pp. 1875-1883
Authors:
Shi, ZT
Afzal, V
Coller, B
Patel, D
Chasis, JA
Parra, M
Lee, G
Paszty, C
Stevens, M
Walensky, L
Peters, LL
Mohandas, N
Rubin, E
Conboy, JG
Citation: Zt. Shi et al., Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities, J CLIN INV, 103(3), 1999, pp. 331-340
Authors:
Bailly, C
Carrasco, C
Hamy, F
Vezin, H
Prudhomme, M
Saleem, A
Rubin, E
Citation: C. Bailly et al., The camptothecin-resistant topoisomerase I mutant F361S is cross-resistantto antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles, BIOCHEM, 38(27), 1999, pp. 8605-8611